210 related articles for article (PubMed ID: 18451138)
1. Protein kinase A effects of an expressed PRKAR1A mutation associated with aggressive tumors.
Meoli E; Bossis I; Cazabat L; Mavrakis M; Horvath A; Stergiopoulos S; Shiferaw ML; Fumey G; Perlemoine K; Muchow M; Robinson-White A; Weinberg F; Nesterova M; Patronas Y; Groussin L; Bertherat J; Stratakis CA
Cancer Res; 2008 May; 68(9):3133-41. PubMed ID: 18451138
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase-A activity in PRKAR1A-mutant cells, and regulation of mitogen-activated protein kinases ERK1/2.
Robinson-White A; Hundley TR; Shiferaw M; Bertherat J; Sandrini F; Stratakis CA
Hum Mol Genet; 2003 Jul; 12(13):1475-84. PubMed ID: 12812976
[TBL] [Abstract][Full Text] [Related]
3. PRKAR1A Mutations and protein kinase A interactions with other signaling pathways in the adrenal cortex.
Robinson-White A; Meoli E; Stergiopoulos S; Horvath A; Boikos S; Bossis I; Stratakis CA
J Clin Endocrinol Metab; 2006 Jun; 91(6):2380-8. PubMed ID: 16569736
[TBL] [Abstract][Full Text] [Related]
4. An immortalized human cell line bearing a PRKAR1A-inactivating mutation: effects of overexpression of the wild-type Allele and other protein kinase A subunits.
Nesterova M; Bossis I; Wen F; Horvath A; Matyakhina L; Stratakis CA
J Clin Endocrinol Metab; 2008 Feb; 93(2):565-71. PubMed ID: 18056771
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD.
Groussin L; Kirschner LS; Vincent-Dejean C; Perlemoine K; Jullian E; Delemer B; Zacharieva S; Pignatelli D; Carney JA; Luton JP; Bertagna X; Stratakis CA; Bertherat J
Am J Hum Genet; 2002 Dec; 71(6):1433-42. PubMed ID: 12424709
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of the Carney complex gene 1 (protein kinase A regulatory subunit 1A) inhibits SMAD3 expression and TGF beta-stimulated apoptosis in adrenocortical cells.
Ragazzon B; Cazabat L; Rizk-Rabin M; Assie G; Groussin L; Fierrard H; Perlemoine K; Martinez A; Bertherat J
Cancer Res; 2009 Sep; 69(18):7278-84. PubMed ID: 19738044
[TBL] [Abstract][Full Text] [Related]
7. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit (PRKAR1A) in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas" (Carney complex).
Stratakis CA
Ann N Y Acad Sci; 2002 Jun; 968():3-21. PubMed ID: 12119264
[TBL] [Abstract][Full Text] [Related]
8. Studies of mice with cyclic AMP-dependent protein kinase (PKA) defects reveal the critical role of PKA's catalytic subunits in anxiety.
Briassoulis G; Keil MF; Naved B; Liu S; Starost MF; Nesterova M; Gokarn N; Batistatos A; Wu TJ; Stratakis CA
Behav Brain Res; 2016 Jul; 307():1-10. PubMed ID: 26992826
[TBL] [Abstract][Full Text] [Related]
9. PRKAR1A gene analysis and protein kinase A activity in endometrial tumors.
Tsigginou A; Bimpaki E; Nesterova M; Horvath A; Boikos S; Lyssikatos C; Papageorgiou C; Dimitrakakis C; Rodolakis A; Stratakis CA; Antsaklis A
Endocr Relat Cancer; 2012 Aug; 19(4):457-62. PubMed ID: 22461635
[TBL] [Abstract][Full Text] [Related]
10. Mutation of Prkar1a causes osteoblast neoplasia driven by dysregulation of protein kinase A.
Pavel E; Nadella K; Towns WH; Kirschner LS
Mol Endocrinol; 2008 Feb; 22(2):430-40. PubMed ID: 17932105
[TBL] [Abstract][Full Text] [Related]
11. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity.
Bertherat J; Groussin L; Sandrini F; Matyakhina L; Bei T; Stergiopoulos S; Papageorgiou T; Bourdeau I; Kirschner LS; Vincent-Dejean C; Perlemoine K; Gicquel C; Bertagna X; Stratakis CA
Cancer Res; 2003 Sep; 63(17):5308-19. PubMed ID: 14500362
[TBL] [Abstract][Full Text] [Related]
12. In vitro functional studies of naturally occurring pathogenic PRKAR1A mutations that are not subject to nonsense mRNA decay.
Greene EL; Horvath AD; Nesterova M; Giatzakis C; Bossis I; Stratakis CA
Hum Mutat; 2008 May; 29(5):633-9. PubMed ID: 18241045
[TBL] [Abstract][Full Text] [Related]
13. Regulatory subunit type I-alpha of protein kinase A (PRKAR1A): a tumor-suppressor gene for sporadic thyroid cancer.
Sandrini F; Matyakhina L; Sarlis NJ; Kirschner LS; Farmakidis C; Gimm O; Stratakis CA
Genes Chromosomes Cancer; 2002 Oct; 35(2):182-92. PubMed ID: 12203783
[TBL] [Abstract][Full Text] [Related]
14. 17q22-24 chromosomal losses and alterations of protein kinase a subunit expression and activity in adrenocorticotropin-independent macronodular adrenal hyperplasia.
Bourdeau I; Matyakhina L; Stergiopoulos SG; Sandrini F; Boikos S; Stratakis CA
J Clin Endocrinol Metab; 2006 Sep; 91(9):3626-32. PubMed ID: 16772351
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of the Carney complex gene 1 (PRKAR1A) alters spatiotemporal regulation of cAMP and cAMP-dependent protein kinase: a study using genetically encoded FRET-based reporters.
Cazabat L; Ragazzon B; Varin A; Potier-Cartereau M; Vandier C; Vezzosi D; Risk-Rabin M; Guellich A; Schittl J; Lechêne P; Richter W; Nikolaev VO; Zhang J; Bertherat J; Vandecasteele G
Hum Mol Genet; 2014 Mar; 23(5):1163-74. PubMed ID: 24122441
[TBL] [Abstract][Full Text] [Related]
16. Activated protein kinase A is required for differentiation-dependent transcription of the decidual prolactin gene in human endometrial stromal cells.
Telgmann R; Maronde E; Taskén K; Gellersen B
Endocrinology; 1997 Mar; 138(3):929-37. PubMed ID: 9048592
[TBL] [Abstract][Full Text] [Related]
17. Cardiac ischemia-reperfusion injury induces ROS-dependent loss of PKA regulatory subunit RIα.
Haushalter KJ; Schilling JM; Song Y; Sastri M; Perkins GA; Strack S; Taylor SS; Patel HH
Am J Physiol Heart Circ Physiol; 2019 Dec; 317(6):H1231-H1242. PubMed ID: 31674811
[TBL] [Abstract][Full Text] [Related]
18. Regulation of cAMP-dependent protein kinases: the human protein kinase X (PrKX) reveals the role of the catalytic subunit alphaH-alphaI loop.
Diskar M; Zenn HM; Kaupisch A; Kaufholz M; Brockmeyer S; Sohmen D; Berrera M; Zaccolo M; Boshart M; Herberg FW; Prinz A
J Biol Chem; 2010 Nov; 285(46):35910-8. PubMed ID: 20819953
[TBL] [Abstract][Full Text] [Related]
19. Haploinsufficiency for either one of the type-II regulatory subunits of protein kinase A improves the bone phenotype of Prkar1a+/- mice.
Liu S; Saloustros E; Mertz EL; Tsang K; Starost MF; Salpea P; Faucz FR; Szarek E; Nesterova M; Leikin S; Stratakis CA
Hum Mol Genet; 2015 Nov; 24(21):6080-92. PubMed ID: 26246497
[TBL] [Abstract][Full Text] [Related]
20. Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutations.
Almeida MQ; Azevedo MF; Xekouki P; Bimpaki EI; Horvath A; Collins MT; Karaviti LP; Jeha GS; Bhattacharyya N; Cheadle C; Watkins T; Bourdeau I; Nesterova M; Stratakis CA
J Clin Endocrinol Metab; 2012 Apr; 97(4):E687-93. PubMed ID: 22259056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
